Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mod Pathol ; 35(11): 1562-1569, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-35840721

RESUMO

Adenoid ameloblastoma is a very rare benign epithelial odontogenic tumor characterized microscopically by epithelium resembling conventional ameloblastoma, with additional duct-like structures, epithelial whorls, and cribriform architecture. Dentinoid deposits, clusters of clear cells, and ghost-cell keratinization may also be present. These tumors do not harbor BRAF or KRAS mutations and their molecular basis appears distinct from conventional ameloblastoma but remains unknown. We assessed CTNNB1 (beta-catenin) exon 3 mutations in a cohort of 11 samples of adenoid ameloblastomas from 9 patients. Two of the 9 patients were female and 7 male and in 7/9 patients the tumors occurred in the maxilla. Tumors of 4 of these 9 patients harbored CTNNB1 mutations, specifically p.Ser33Cys, p.Gly34Arg, and p.Ser37Phe. Notably, for one patient 3 samples were analyzed including the primary tumour and two consecutive recurrences, and results were positive for the mutation in all three tumors. Therefore, 6/11 samples tested positive for the mutation. In the 6 mutation-positive samples, ghost cells were present in only 2/6, indicating beta-catenin mutations are not always revealed by ghost cell formation. Dentinoid matrix deposition was observed in 5/6 mutation-positive samples and clear cells in all 6 cases. None of the cases harbored either BRAF or KRAS mutations. Beta-catenin immunoexpression was assessed in the samples of 8 patients. Except for one wild-type case, all cases showed focal nuclear expression irrespective of the mutational status. Together with the absence of BRAF mutation, the detection of beta-catenin mutation in adenoid ameloblastomas supports its classification as a separate entity, and not as a subtype of ameloblastoma. The presence of this mutation may help in the diagnosis of challenging cases.


Assuntos
Tonsila Faríngea , Ameloblastoma , Tumores Odontogênicos , Humanos , Masculino , Feminino , Ameloblastoma/genética , Ameloblastoma/patologia , beta Catenina/genética , beta Catenina/metabolismo , Proteínas Proto-Oncogênicas B-raf/genética , Tonsila Faríngea/metabolismo , Tonsila Faríngea/patologia , Proteínas Proto-Oncogênicas p21(ras)/genética , Proteínas Proto-Oncogênicas p21(ras)/metabolismo , Tumores Odontogênicos/patologia , Mutação
2.
Int J Surg Pathol ; 27(5): 561-567, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30714449

RESUMO

Ewing sarcomas are typified by EWSR1 fusion to ETS gene family members. Tumors with fusion partners other than ETS family members and atypical histologic features pose significant diagnostic challenges and controversies as to their classification. In this article, we report a tumor with EWSR1-NFATC2 fusion in the left femur of a 43-year-old man and with unusual morphologic features that resemble undifferentiated high-grade sarcoma. Analysis together with reported cases in the literature shows that tumors with EWSR1-NFATC2 exhibit distinctive clinicopathologic features, including predilection for young male adults, highly variable histology that varies from round cell tumors frequently associated with nuclear irregularity, short spindle cells with nuclear pleomorphism, to myoepithelial tumor-like with or without myxohyaline matrix. They show variable positivity to CD99, frequent expression of cytokeratins, and consistent high-level amplification of EWSR1-NFATC2 fusion gene with distinctive gene expression profile. These tumors thus deserve classification separate from Ewing sarcoma.


Assuntos
Neoplasias Ósseas/diagnóstico , Fêmur/patologia , Proteínas de Fusão Oncogênica/genética , Osteossarcoma/diagnóstico , Sarcoma de Ewing/diagnóstico , Antígeno 12E7/metabolismo , Adulto , Amputação Cirúrgica , Biópsia , Neoplasias Ósseas/genética , Neoplasias Ósseas/terapia , Quimioterapia Adjuvante , Diagnóstico Diferencial , Fêmur/cirurgia , Amplificação de Genes , Humanos , Masculino , Metotrexato/uso terapêutico , Osteossarcoma/genética , Osteossarcoma/terapia , Sarcoma de Ewing/genética , Sarcoma de Ewing/patologia , Resultado do Tratamento
4.
J Endourol ; 29(6): 714-7, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25353613

RESUMO

INTRODUCTION: There are different types of transurethral prostatic surgeries and the complication profiles are different. This study aims to compare the heat damage zones (HDZ) created by five different technologies in a pig liver model. MATERIALS AND METHODS: Monopolar resection, bipolar resection, electrovaporization, and Greenlight™ lasers of 120 and 180 W were used to remove fresh pig liver tissue in a simulated model. Each procedure was repeated in five specimens. Two blocks were selected from each specimen to measure the three deepest HDZ. RESULTS: The mean of HDZ was 295, 234, 192, 673, and 567 µm, respectively, for monopolar resection, bipolar resection, electrovaporization, Greenlight laser 120 W, and Greenlight laser 180 W, respectively. The Greenlight laser produced one to three times deeper HDZ than the other energy sources (p=0.000). CONCLUSION: Both 120 and 180 W Greenlight lasers produced deeper HDZ than the other energy sources. Urologists need to be aware of HDZ that cause tissue damage outside the operative field.


Assuntos
Temperatura Alta , Terapia a Laser/efeitos adversos , Fígado/patologia , Complicações Pós-Operatórias/etiologia , Hiperplasia Prostática/cirurgia , Ressecção Transuretral da Próstata/efeitos adversos , Animais , Modelos Animais de Doenças , Humanos , Terapia a Laser/métodos , Masculino , Complicações Pós-Operatórias/prevenção & controle , Suínos , Ressecção Transuretral da Próstata/métodos , Resultado do Tratamento
7.
Acta Cytol ; 47(5): 809-16, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14526684

RESUMO

BACKGROUND: Systemic anaplastic large cell lymphoma (ALCL) is predominantly a nodal disease, but extranodal involvement can occur during the disease course or as the primary presentation. We report two rare cases of ALCL presenting with a pleural effusion, mimicking primary effusion lymphoma (PEL). CASES: Two patients, a 47-year-old woman and an 81-year-old man, presented with a pleural effusion for investigation. The pleural fluid contained abundant, large, lymphoid cells with marked nuclear atypia. These neoplastic cells strongly expressed CD30 and EMA and showed a T-cell phenotype (CD3+CD45RO+ for case 1 and CD4+ for case 2). Case 1, in addition, showed ALK1 expression. The tumor cells in both cases were negative for human herpes virus type 8 (HHV8) and Epstein-Barr virus (EBV). ALCL shows overlapping cytologic features with PEL, but the T-cell phenotype, ALK1 expression in case 1, lack of association with HHV8 and EBV, HIV seronegativity and subsequent discovery of nodal disease in case 2 were all in favor of ALCL over PEL. CONCLUSION: In rare cases a pleural effusion is the presenting feature of ALCL, and distinction from PEL depends on correlation with clinical findings, detailed immunophenotyping and study of the status of HHV8 and EBV.


Assuntos
Linfoma Anaplásico de Células Grandes/diagnóstico , Derrame Pleural Maligno/diagnóstico , Idoso , Idoso de 80 Anos ou mais , Quinase do Linfoma Anaplásico , Antígenos CD/metabolismo , Diagnóstico Diferencial , Feminino , Humanos , Técnicas Imunoenzimáticas , Imunofenotipagem , Linfoma Anaplásico de Células Grandes/enzimologia , Masculino , Pessoa de Meia-Idade , Derrame Pleural Maligno/enzimologia , Proteínas Tirosina Quinases/metabolismo , Receptores Proteína Tirosina Quinases
8.
Arch Pathol Lab Med ; 127(7): 872-5, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12823046

RESUMO

We report an unusual case of ependymoma with pigmentation, a phenomenon that has only been described in a few cases, to our knowledge. This tumor occurred in the fourth ventricle of a 45-year-old man. It showed the typical histologic appearance of ependymoma with perivascular pseudorosettes and rare ependymal rosettes. Some tumor cells contained brown cytoplasmic pigment, which was shown histochemically to represent a mixture of lipofuscin and neuromelanin. The pigment was positive for acid-fast and periodic acid-Schiff stains and was also focally positive for Masson-Fontana and Schmorl stains (bleached by pretreatment with potassium permanganate). In addition, some other tumor cells showed a signet ring morphology as a result of prominent intracytoplasmic vacuolation. Immunohistochemically, all the tumor cells expressed glial fibrillary acidic protein, and rare pigmented tumor cells also expressed HMB-45. Ultrastructural examination showed irregularly shaped heterogeneous electron-dense bodies corresponding to the pigment, and the cytoplasmic vacuoles were formed by dilatation of intracytoplasmic lumens lined by microvilli. Since lipofuscin production can occur in normal ependymal cells and neuromelanin has been suggested to be a melanized form of lipofuscin, it is not surprising that these 2 pigments can be found in ependymoma. In all the previously reported cases, the pigment was shown to represent melanin only. In our case, the HMB-45 positivity in rare tumor cells indicated that there might also be a minor melanin component in the pigment in addition to lipofuscin and neuromelanin.


Assuntos
Neoplasias Cerebelares/diagnóstico , Ependimoma/diagnóstico , Lipofuscina/biossíntese , Melaninas/biossíntese , Neoplasias Cerebelares/química , Neoplasias Cerebelares/radioterapia , Neoplasias Cerebelares/cirurgia , Ependimoma/química , Ependimoma/radioterapia , Ependimoma/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...